Logo image of CLMT

CALUMET INC (CLMT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CLMT - US1314281049 - Common Stock

20.1 USD
+0.21 (+1.06%)
Last: 1/14/2026, 4:30:00 PM
20.1 USD
0 (0%)
After Hours: 1/14/2026, 4:30:00 PM
Fundamental Rating

2

Taking everything into account, CLMT scores 2 out of 10 in our fundamental rating. CLMT was compared to 208 industry peers in the Oil, Gas & Consumable Fuels industry. CLMT may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CLMT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • CLMT had negative earnings in the past year.
  • In the past year CLMT has reported a negative cash flow from operations.
  • In the past 5 years CLMT reported 4 times negative net income.
  • In multiple years CLMT reported negative operating cash flow during the last 5 years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.36%, CLMT is doing worse than 72.12% of the companies in the same industry.
  • With a Return On Invested Capital value of 5.73%, CLMT perfoms like the industry average, outperforming 51.92% of the companies in the same industry.
  • CLMT had an Average Return On Invested Capital over the past 3 years of 7.03%. This is significantly below the industry average of 21.83%.
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROIC 5.73%
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.03%
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

  • The Operating Margin of CLMT (3.51%) is worse than 66.83% of its industry peers.
  • CLMT's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 8.21%, CLMT is doing worse than 72.60% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CLMT has declined.
Industry RankSector Rank
OM 3.51%
PM (TTM) N/A
GM 8.21%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

1

2. Health

2.1 Basic Checks

  • CLMT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CLMT has more shares outstanding than it did 1 year ago.
  • CLMT has more shares outstanding than it did 5 years ago.
  • CLMT has a worse debt/assets ratio than last year.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • CLMT has an Altman-Z score of 1.21. This is a bad value and indicates that CLMT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CLMT (1.21) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.21
ROIC/WACC0.58
WACC9.97%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.13 indicates that CLMT should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.13, CLMT perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • CLMT has a Quick Ratio of 1.13. This is a bad value and indicates that CLMT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.62, CLMT is doing worse than 69.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.62
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 58.33% over the past year.
  • The Revenue for CLMT has decreased by -22.49% in the past year. This is quite bad
  • Measured over the past years, CLMT shows a small growth in Revenue. The Revenue has been growing by 3.94% on average per year.
EPS 1Y (TTM)58.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%405.93%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-2.04%

3.2 Future

  • Based on estimates for the next years, CLMT will show a very strong growth in Earnings Per Share. The EPS will grow by 29.17% on average per year.
  • The Revenue is expected to grow by 5.84% on average over the next years.
EPS Next Y94.2%
EPS Next 2Y41.83%
EPS Next 3Y30.53%
EPS Next 5Y29.17%
Revenue Next Year1.96%
Revenue Next 2Y-0.25%
Revenue Next 3Y5.96%
Revenue Next 5Y5.84%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • CLMT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 656.86, which means the current valuation is very expensive for CLMT.
  • Based on the Price/Forward Earnings ratio, CLMT is valued a bit more expensive than the industry average as 67.79% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, CLMT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 656.86
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLMT is valued a bit more expensive than 65.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.97
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLMT does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as CLMT's earnings are expected to grow with 30.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.83%
EPS Next 3Y30.53%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for CLMT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CALUMET INC

NASDAQ:CLMT (1/14/2026, 4:30:00 PM)

After market: 20.1 0 (0%)

20.1

+0.21 (+1.06%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-07
Earnings (Next)02-26
Inst Owners52.96%
Inst Owner Change0.02%
Ins Owners2.98%
Ins Owner Change-0.16%
Market Cap1.74B
Revenue(TTM)4.05B
Net Income(TTM)-37.20M
Analysts78.33
Price Target22.25 (10.7%)
Short Float %11.64%
Short Ratio11.34
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)369.74%
Min EPS beat(2)-407.62%
Max EPS beat(2)1147.11%
EPS beat(4)2
Avg EPS beat(4)105.83%
Min EPS beat(4)-407.62%
Max EPS beat(4)1147.11%
EPS beat(8)4
Avg EPS beat(8)44.84%
EPS beat(12)6
Avg EPS beat(12)-404.2%
EPS beat(16)6
Avg EPS beat(16)-335.84%
Revenue beat(2)2
Avg Revenue beat(2)4.63%
Min Revenue beat(2)0.47%
Max Revenue beat(2)8.78%
Revenue beat(4)4
Avg Revenue beat(4)4.89%
Min Revenue beat(4)0.47%
Max Revenue beat(4)9.31%
Revenue beat(8)8
Avg Revenue beat(8)7.08%
Revenue beat(12)11
Avg Revenue beat(12)7.22%
Revenue beat(16)15
Avg Revenue beat(16)10.04%
PT rev (1m)0%
PT rev (3m)8.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-71.18%
EPS NY rev (1m)77.27%
EPS NY rev (3m)96.55%
Revenue NQ rev (1m)0.39%
Revenue NQ rev (3m)-4.59%
Revenue NY rev (1m)1.76%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 656.86
P/S 0.43
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 13.97
EPS(TTM)-1.15
EYN/A
EPS(NY)0.03
Fwd EY0.15%
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS46.66
BVpS-8.01
TBVpS-8.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROCE 7.26%
ROIC 5.73%
ROICexc 6.03%
ROICexgc 6.03%
OM 3.51%
PM (TTM) N/A
GM 8.21%
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.03%
ROIC(5y)N/A
ROICexc(3y)7.12%
ROICexc(5y)N/A
ROICexgc(3y)8.23%
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-44.77%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.65%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
F-Score4
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.38
Cap/Depr 43.36%
Cap/Sales 1.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.62
Altman-Z 1.21
F-Score4
WACC9.97%
ROIC/WACC0.58
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%405.93%
EPS Next Y94.2%
EPS Next 2Y41.83%
EPS Next 3Y30.53%
EPS Next 5Y29.17%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-2.04%
Revenue Next Year1.96%
Revenue Next 2Y-0.25%
Revenue Next 3Y5.96%
Revenue Next 5Y5.84%
EBIT growth 1Y1018.9%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year3138.83%
EBIT Next 3Y274.32%
EBIT Next 5Y148.39%
FCF growth 1Y83.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.87%
OCF growth 3YN/A
OCF growth 5YN/A

CALUMET INC / CLMT FAQ

What is the ChartMill fundamental rating of CALUMET INC (CLMT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLMT.


What is the valuation status for CLMT stock?

ChartMill assigns a valuation rating of 1 / 10 to CALUMET INC (CLMT). This can be considered as Overvalued.


Can you provide the profitability details for CALUMET INC?

CALUMET INC (CLMT) has a profitability rating of 1 / 10.


What is the earnings growth outlook for CALUMET INC?

The Earnings per Share (EPS) of CALUMET INC (CLMT) is expected to grow by 94.2% in the next year.


Is the dividend of CALUMET INC sustainable?

The dividend rating of CALUMET INC (CLMT) is 0 / 10 and the dividend payout ratio is 0%.